Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-006495
Filing Date
2024-11-14
Accepted
2024-11-14 06:34:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 p24-3257sc13g.htm SC 13G 61094
2 JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K) p24-3257exhibit99.htm EX-99.1 4376
  Complete submission text file 0000902664-24-006495.txt   67098
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Subject) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91706 | Film No.: 241456987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)